tacforius
teva b.v. - takrolimuusimonohydraatti - liver transplantation; kidney transplantation - immunosuppressantit - aivojen munuaisten tai maksan allograftin vastaanottajien profylaksi. allograftin hylkimisen hoito, joka on resistentti hoidossa muiden immunosuppressiivisten lääkevalmisteiden kanssa aikuisilla potilailla.
darunavir medical valley 400 mg tabletti, kalvopäällysteinen
medical valley invest ab - darunavir propylene glycolate - tabletti, kalvopäällysteinen - 400 mg - darunaviiri
darunavir medical valley 600 mg tabletti, kalvopäällysteinen
medical valley invest ab - darunavir propylene glycolate - tabletti, kalvopäällysteinen - 600 mg - darunaviiri
darunavir accord 400 mg tabletti, kalvopäällysteinen
accord healthcare b.v. - darunavir propylene glycolate - tabletti, kalvopäällysteinen - 400 mg - darunaviiri
darunavir accord 600 mg tabletti, kalvopäällysteinen
accord healthcare b.v. - darunavir propylene glycolate - tabletti, kalvopäällysteinen - 600 mg - darunaviiri
darunavir accord 800 mg tabletti, kalvopäällysteinen
accord healthcare b.v. - darunavir propylene glycolate - tabletti, kalvopäällysteinen - 800 mg - darunaviiri
lumeblue (previously known as methylthioninium chloride cosmo)
alfasigma s.p.a. - metyylitioniniumkloridia - colorectal neoplasms; colonoscopy - other diagnostic agents - lumeblue is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.
copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastiset aineet - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.